849 related articles for article (PubMed ID: 26469045)
21. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
22. Pharmacogenomics research and its clinical implementation in Thailand: Lessons learned from the resource-limited settings.
Sukasem C; Jantararoungtong T; Koomdee N
Drug Metab Pharmacokinet; 2021 Aug; 39():100399. PubMed ID: 34098253
[TBL] [Abstract][Full Text] [Related]
23. Pharmacogenetics and outcome with antipsychotic drugs.
Pouget JG; Shams TA; Tiwari AK; Müller DJ
Dialogues Clin Neurosci; 2014 Dec; 16(4):555-66. PubMed ID: 25733959
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenomics: personalizing pediatric heart transplantation.
Van Driest SL; Webber SA
Circulation; 2015 Feb; 131(5):503-12. PubMed ID: 25645611
[No Abstract] [Full Text] [Related]
25. Pharmacogenetics of Clopidogrel Therapy and Neurointerventional Procedures: We Need Precision Data for Precision Medicine.
Rakicevic L; Nestorovic A
Clin Pharmacol Ther; 2019 Mar; 105(3):547-549. PubMed ID: 29920652
[TBL] [Abstract][Full Text] [Related]
26. On the readiness of physicians for pharmacogenomics testing: an empirical assessment.
Amara N; Blouin-Bougie J; Bouthillier D; Simard J
Pharmacogenomics J; 2018 Apr; 18(2):308-318. PubMed ID: 28607504
[TBL] [Abstract][Full Text] [Related]
27. Clinical implementation of pharmacogenomics via a health system-wide research biobank: the University of Colorado experience.
Aquilante CL; Kao DP; Trinkley KE; Lin CT; Crooks KR; Hearst EC; Hess SJ; Kudron EL; Lee YM; Liko I; Lowery J; Mathias RA; Monte AA; Rafaels N; Rioth MJ; Roberts ER; Taylor MR; Williamson C; Barnes KC
Pharmacogenomics; 2020 Apr; 21(6):375-386. PubMed ID: 32077359
[TBL] [Abstract][Full Text] [Related]
28. Integrating pharmacogenomics into electronic health records with clinical decision support.
Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
[TBL] [Abstract][Full Text] [Related]
29. Pharmacogenes (PGx-genes): Current understanding and future directions.
Katara P; Yadav A
Gene; 2019 Nov; 718():144050. PubMed ID: 31425740
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
31. Conference scene: pediatric pharmacogenomics and personalized medicine.
Leeder JS; Lantos J; Spielberg SP
Pharmacogenomics; 2010 Dec; 11(12):1691-702. PubMed ID: 21142913
[TBL] [Abstract][Full Text] [Related]
32. The value of routine pharmacogenomic screening-Are we there yet? A perspective on the costs and benefits of routine screening-shouldn't everyone have this done?
Veenstra DL
Clin Pharmacol Ther; 2016 Feb; 99(2):164-6. PubMed ID: 26565561
[TBL] [Abstract][Full Text] [Related]
33. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.
Arbitrio M; Di Martino MT; Scionti F; Agapito G; Guzzi PH; Cannataro M; Tassone P; Tagliaferri P
Oncotarget; 2016 Aug; 7(33):54028-54050. PubMed ID: 27304055
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics in pediatrics: personalized medicine showing eminent promise.
Mele C; Goldschmidt K
J Pediatr Nurs; 2014; 29(4):378-82. PubMed ID: 24880100
[No Abstract] [Full Text] [Related]
35. Precision Medicine.
Khatri VP; Petrelli NJ
Surg Oncol Clin N Am; 2020 Jan; 29(1):xv-xvi. PubMed ID: 31757318
[No Abstract] [Full Text] [Related]
36. Personalized medicine, pharmacogenomic and companion biomarker.
Manceau H; Amrani K; Peoc'h K
Ann Biol Clin (Paris); 2017 Dec; 75(6):631-636. PubMed ID: 29192598
[TBL] [Abstract][Full Text] [Related]
37. "Pharmacogenomics: achievements, challenges and prospects, for patients, pharmaceutical industries and healthcare systems".
Sanoudou D
Curr Pharm Des; 2010; 16(20):2182-3. PubMed ID: 20459384
[No Abstract] [Full Text] [Related]
38. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
[TBL] [Abstract][Full Text] [Related]
39. PharmGKB: understanding the effects of individual genetic variants.
Sangkuhl K; Berlin DS; Altman RB; Klein TE
Drug Metab Rev; 2008; 40(4):539-51. PubMed ID: 18949600
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenomics and personalized medicine in clinical practice.
Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
